scispace - formally typeset
L

Louis Boon

Researcher at University of Amsterdam

Publications -  383
Citations -  20067

Louis Boon is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 70, co-authored 358 publications receiving 16801 citations. Previous affiliations of Louis Boon include Janssen Pharmaceutica & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

TL;DR: The sole application of the innate TLR7/8 ligand IMQ rapidly induces a dermatitis closely resembling human psoriasis, critically dependent on the IL-23/IL-17 axis.
Journal ArticleDOI

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

TL;DR: It is found that IDO was involved in intracellular signaling events responsible for the self-amplification and maintenance of a stably regulatory phenotype in pDCs and has a tonic, nonenzymic function that contributes to TGF-β-driven tolerance in noninflammatory contexts.
Journal ArticleDOI

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.

TL;DR: It is shown that reverse signaling through GITRL after engagement by soluble GITR initiates the immunoregulatory pathway of tryptophan catabolism in mouse plasmacytoid dendritic cells, by means of noncanonical NF-κB–dependent induction of indoleamine 2,3-dioxygenase (IDO).
Journal ArticleDOI

Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs

TL;DR: The findings suggest that during MS and EAE, modulation of T cell reactivity against brain-derived Ags also takes place in cervical LN and not necessarily inside the brain, thereby circumventing the blood-brain barrier.